Highlights
- 1Cell reports · 2020
- 2Science advances · 2022
- 3Reproduction (Cambridge, England) · 2022
Publications
18 publications
Funding
2 grants
Active
1 grant- Co-IR01HD112441-01Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028
Completed grants (1)
- Co-IR21HD103956-01A1Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girlsEunice Kennedy Shriver National Institute of Child Health and Human Development · 2021–2024
Clinical research
1 study
Active
1 study- PIUnfolding a correlation between sequential analysis results for FMR1 gene of the parental sequence to the embryos' utilizing PGD resultsWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
News mentions
1 mentionView all WCM news ↗
- Anti-Müllerian Hormone May Contribute to Infertility in Polycystic Ovary SyndromeMarch 9, 2022
High levels of anti-Mullerian hormone (AMH) have traditionally been thought of as merely a passive byproduct of polycystic ovary syndrome (PCOS), but a new preclinical study by Weill Cornell Medicine researchers suggests that the hormone plays an active role in the disorder and may contribute to problems with ovulation and fertility.